Concepedia

Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis

Francisco Sylvester, Dan Turner, Andrew Draghi, Krista Uuosoe, Robin McLernon, Kristen Koproske, David Mack, Wallace Crandall, Jeffrey S. Hyams, Neal S. LeLeiko,

Inflammatory Bowel Diseases · 2010 · 49 citations · 20 references

DOI

Abstract

Day 3 fecal OPG may guide the decision to institute second-line therapy in children with severe UC. The role of OPG in the inflammatory response in pediatric UC deserves further study.

References

20

Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density

W. Scott Simonet, Dave Lacey, Colin R. Dunstan et al. · Cell · 1997 · 5.1K citations · Full text

, , +13

Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL

John G. Emery, Peter McDonnell, Michael Brigham Burke et al. · Journal of Biological Chemistry · 1998 · 1.2K citations · Full text

Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study

Dan Turner, Anthony Otley, David R. Mack et al. · Gastroenterology · 2007 · 1K citations · Full text

, , +6

Differentiating Ulcerative Colitis from Crohn Disease in Children and Young Adults: Report of a Working Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America

Journal of Pediatric Gastroenterology and Nutrition · 2007 · 531 citations

Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis

Monica Boirivant, Marco Marini, Gabriella Di Felice et al. · Gastroenterology · 1999 · 269 citations · Full text

, , +9